CCS
LMAT icon

Crosspoint Capital Strategies’s LeMaitre Vascular LMAT Stock Holding History

Crosspoint Capital Strategies’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-288
Closed -$92K – 51
2017
Q4 		$92K Buy
288
+76
+36% +$2.6K 0.01% 105
2017
Q3 		$8K Sell
212
-24
-10% -$817 0.01% 97
2017
Q2 		$7K Sell
236
-72
-23% -$2.08K 0.01% 87
2017
Q1 		$8K Hold
308
– – 0.01% 75
2016
Q4 		$8K Buy
+308
New +$6.84K 0.01% 73

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Crosspoint Capital Strategies's LMAT Position: Q1 2018 in Review

Crosspoint Capital Strategies sold out of LeMaitre Vascular (LMAT) in Q1 2018, closing a stake of 288 shares — an estimated $92K sold.

Crosspoint Capital Strategies first reported a position in LMAT in Q4 2016 and held it in 5 quarters. The position peaked at $92K in Q4 2017. 154 funds tracked by Wall St. Rank hold LMAT as of Q1 2018.

  • Crosspoint Capital Strategies reported no remaining LeMaitre Vascular position as of Q1 2018 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 288 LeMaitre Vascular shares in Q1 2018, an estimated $92K.
  • Crosspoint Capital Strategies first reported a position in LeMaitre Vascular in Q4 2016 and held it in 5 quarters.
  • Crosspoint Capital Strategies's LeMaitre Vascular position peaked at $92K in Q4 2017.
  • 154 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2018.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2018, filed 14 May 2018.